{
    "2021-10-29": [
        [
            {
                "time": "2021-10-26",
                "original_text": "贝莱德10月26日增持11.84万股泰格医药股份，涉资1786.79万港元",
                "features": {
                    "keywords": [
                        "贝莱德",
                        "增持",
                        "泰格医药",
                        "11.84万股",
                        "1786.79万港元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-10-29",
                "original_text": "泰格医药(03347.HK)10月29日耗资227.44万元回购1.4万股A股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "回购",
                        "227.44万元",
                        "1.4万股",
                        "A股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-29",
                "original_text": "【权益变动】泰格医药(03347.HK)被Aggregate of abrdn affiliated investment减持3.47万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "减持",
                        "3.47万股",
                        "Aggregate of abrdn affiliated investment"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-29",
                "original_text": "中信建投医药大健康团队最新研究",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "大健康",
                        "研究"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "大健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}